Skip to content
Study details
Enrolling now

Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis

University of Maryland, Baltimore
NCT IDNCT05440214ClinicalTrials.gov data as of Apr 2026
Target enrollment

68

Study length

about 4.1 years

Ages

18+

Locations

1 site in MD

About this study

This trial is testing a treatment that targets emotion dysregulation in people with psychotic disorders. The goal is to see if this intervention can reduce suicide risk in this population.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Participate in Dialectical Behavior Therapy Skills Training

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low4%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Body systems

Psychiatry / Mental Health